|Dr. Omid C. Farokhzad Ph.D., M.D.||Founder, CEO & Chair of the Board of Directors||972.08k||N/A||1969|
|Mr. Omead Ostadan||Pres, COO & Director||745.74k||N/A||1972|
|Mr. David R. Horn||Exec. VP & Chief Financial Officer||554.29k||N/A||1968|
|Mr. Joe Laws||Chief Technology Officer and Co-Founder||N/A||N/A||N/A|
|Ms. Elona Kogan J.D., Esq.||Gen. Counsel & Sec.||N/A||N/A||1969|
|Ms. Karen Possemato||VP of Corp. Marketing & Communications||N/A||N/A||N/A|
|Mr. Shashanka Muppaneni||VP of Corp. Devel.||N/A||N/A||N/A|
|Ms. Marissa Dixon||VP & Chief People Officer||N/A||N/A||N/A|
|Dr. Serafim Batzoglou||VP & Chief of Computation||N/A||N/A||N/A|
|Ms. Jennifer Maggio||VP & Corp. Controller||N/A||N/A||N/A|
Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Seer, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.